QCM
AVXL icon

Quantinno Capital Management’s Anavex Life Sciences AVXL Stock Holding History

Quantinno Capital Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$167K Buy
54,547
+8,836
+19% +$38.3K ﹤0.01% 3218
2025
Q4 		$163K Buy
45,711
+11,437
+33% +$70.1K ﹤0.01% 3086
2025
Q3 		$305K Buy
34,274
+6,986
+26% +$70.9K ﹤0.01% 2441
2025
Q2 		$252K Buy
27,288
+4,279
+19% +$36.5K ﹤0.01% 2162
2025
Q1 		$197K Buy
+23,009
New +$217K ﹤0.01% 1891

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Quantinno Capital Management's AVXL Position: Q1 2026 in Review

Quantinno Capital Management increased its Anavex Life Sciences (AVXL) stake by 19% in Q1 2026, buying an estimated $38.3K and bringing the position to 54,547 shares worth $167K. The position accounts for ﹤0.01% of the portfolio, ranked #3218.

Quantinno Capital Management first reported a position in AVXL in Q1 2025 and has held it in 5 quarters since. The position peaked at $305K in Q3 2025. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Quantinno Capital Management held 54,547 shares of Anavex Life Sciences worth $167K as of Q1 2026.
  • Quantinno Capital Management bought 8,836 Anavex Life Sciences shares in Q1 2026, an estimated $38.3K.
  • Anavex Life Sciences made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #3218 holding.
  • Quantinno Capital Management first reported a position in Anavex Life Sciences in Q1 2025 and has held it in 5 quarters since.
  • Quantinno Capital Management's Anavex Life Sciences position peaked at $305K in Q3 2025.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.